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BRAINSTEM CHOLINERGIC MODULATION OF MUSCLE TONE IN
INFANT RATS
Andrew J. Gall, Amy Poremba, and Mark S. Blumberg
Program in Behavioral and Cognitive Neuroscience, Department of Psychology, University of Iowa,
Iowa City, IA, 52242, USA
Abstract
In week-old rats, lesions of the dorsolateral pontine tegmentum (DLPT) and nucleus pontis oralis
(PnO) have opposing effects on nuchal muscle tone. Specifically, pups with DLPT lesions exhibit
prolonged bouts of nuchal muscle atonia (indicative of sleep) and pups with PnO lesions exhibit
prolonged bouts of high nuchal muscle tone (indicative of wakefulness). Here we test the hypothesis
that nuchal muscle tone is modulated, at least in part, by cholinergically mediated interactions
between these two regions. First, in unanesthetized pups, we found that chemical infusion of the
cholinergic agonist carbachol (22 mM, 0.1 µL) within the DLPT produced high muscle tone. Next,
chemical lesions of the nucleus pontis oralis (PnO) were used to produce a chronic state of high
nuchal muscle tone, at which time the cholinergic antagonist scopolamine (10 mM, 0.1 µL) was
infused into the DLPT. Scopolamine effectively decreased nuchal muscle tone, thus suggesting that
lesions of the PnO increase muscle tone via cholinergic activation of the DLPT. Using 2-
deoxyglucose (2-DG) autoradiography, metabolic activation throughout the DLPT was observed
after PnO lesions. Finally, consistent with the hypothesis that PnO inactivation produces high muscle
tone, infusion of the sodium channel blocker, lidocaine (2%), into the PnO of unanesthetized pups
produced rapid increases in muscle tone. We conclude that, even early in infancy, the DLPT is
critically involved in the regulation of muscle tone and behavioral state and that its activity is
modulated by a cholinergic mechanism that is directly or indirectly controlled by the PnO.
Keywords
Acetylcholine; carbachol; 2-deoxyglucose; autoradiography; EMG; development
Infant rats cycle more rapidly than adults between sleep and wakefulness (Kleitman &
Engelmann, 1953; Blumberg et al., 2005). One of the challenges for sleep researchers is to
reveal the neural circuits that generate this cyclicity as well as the processes underlying the
dramatic developmental changes that mediate the transition to the more stable and persistent
sleep and wake durations characteristic of adults (Lo et al., 2002; Lo et al., 2004; Blumberg
et al., 2005).
We have learned much in recent years about the brainstem mechanisms that produce sleep and
wakefulness in infants (Karlsson et al., 2005; Karlsson & Blumberg, 2005). Specifically, we
recently reported that the dorsolateral pontine tegmentum (DLPT), which includes the
laterodorsal tegmental nucleus (LDT), the pedunculopontine tegmental nucleus (PPT), and the
parabrachial nucleus (PB), contributes to wakefulness in infant rats (Karlsson et al., 2005).
Within the DLPT, neurons were identified that increased their activity during periods of high
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nuchal muscle tone (indicative of wakefulness) and, when lesions were produced within this
region, pups slept 97% of the time. Conversely, many sleep-related neurons were identified
within the nucleus pontis oralis (PnO) and, when lesions were produced within this region,
pups were awake 70% of the time. These reciprocal effects of DLPT and PnO lesions on sleep
and wakefulness suggest that interactions between these two areas help mediate transitions
between behavioral states in early infancy.
Based on evidence in adults that muscarinic receptors are found throughout the DLPT
(Baghdoyan, 1997), we hypothesized that acetylcholine modulates activity in this region to
produce the high muscle tone normally indicative of wakefulness. Thus, we predicted that
infusing the cholinergic agonist carbachol into the DLPT would induce sustained periods of
high muscle tone. We also predicted that blocking cholinergic activity within the DLPT using
the cholinergic antagonist scopolamine would inhibit the persistent increase in muscle tone
produced by chemical lesions of the PnO. Next, using 2-deoxyglucose (2-DG)
autoradiography, we mapped metabolic activity within the brainstem, including the DLPT,
after PnO lesions. Finally, to confirm that it is the inactivation of neurons within the PnO that
produces the observed effect on muscle tone, as would be expected from stimulation studies
in adults (Hajnik et al., 2000), we infused the sodium channel blocker, lidocaine, into the PnO
of unanesthetized pups. All together, our results indicate direct or indirect cholinergic
communication between neurons in the PnO and DLPT and suggest that these areas form key
parts of the brainstem neural circuit upon which sleep-wake cyclicity in infants depends and
upon which the adult system is built.
MATERIALS AND METHODS
All experiments were performed in accordance with National Institutes of Health guidelines
for the care of animals in research and were approved by the Institutional Animal Care and
Use Committee of the University of Iowa.
SUBJECTS
In total, 28 8–10-day-old (P8–10) Sprague-Dawley rats from 26 litters were used. Males and
females were equally represented in all experiments. Body weights were 17.0 – 22.6 g. The
pups were raised in litters that were culled to 8 pups within 3 days of birth (day of birth = P0).
Mothers and their litters were housed and raised in standard laboratory cages (48 cm long ×
20 cm wide × 26 cm high) in the animal colony at the University of Iowa. Food and water were
available to the animals ad libitum. All animals were maintained on a 12-h light-dark schedule
with lights on at 7:00 am. All experiments were conducted during the lights-on phase.
PROCEDURE
Experiment 1: Chemical stimulation of the DLPT with carbachol—Chemical
stimulations were performed using 12 P8–10 rats (equally divided between males and females)
from 12 litters. Under isoflurane anesthesia, two bipolar stainless steel electromyogram (EMG)
electrodes (50µm diameter, California Fine Wire, Grover Beach, CA) were inserted bilaterally
into the nuchal muscles. (In 8 of these subjects, extraocular EMG data were also collected, as
described previously (Seelke & Blumberg, 2005). These data are not discussed further below
because they provided redundant information. In all subsequent experiments, only nuchal
EMGs are implanted.) The skull was bleached and then coated with Vetbond (3M, St. Paul,
Minnesota, United States) to strengthen the infant's fragile skull. Next, a T-shaped, stainless
steel apparatus was attached to the skull using cyanoacrylate adhesive gel in order to secure
and stabilize the skull in the stereotaxic apparatus. Finally, the pup was wrapped in gauze to
both secure the pup and induce sleep (Corner & Kwee, 1976). Pups were then placed into a
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humidified incubator maintained at thermoneutrality (i.e., 35°C) for 1–2 h to recover from
surgery.
Using methods described previously (Karlsson & Blumberg, 2005), the subject was placed in
a stereotaxic apparatus (David Kopf Instruments, Tujunga, California, United States) under
thermoneutral conditions. Pups were allowed to acclimate for 1 h prior to stimulation. Nuchal
EMG electrodes were connected to a differential amplifier (A-M Systems, Carlsborg, WA),
and their signals were amplified (x10,000) and filtered (300–3000 Hz). EMG data were
sampled at 12,500 Hz using a digital interface (Model 1401, CED, Cambridge, England), and
visualized using Spike2 software (CED, Cambridge, England). Data collection began when
the subject exhibited normal sleep-wake cyclicity. For this purpose, sleep was defined as low-
amplitude EMG activity with or without the presence of myoclonic twitches, and wake was
defined as high-amplitude EMG activity (Karlsson & Blumberg, 2002; Seelke & Blumberg,
2005).
A 0.5 µl 32-gauge microsyringe (Model 7000.5OC; Hamilton Co., Reno, NV) was lowered
into the DLPT (coordinates relative to lambda; AP, −1.2 mm; ML, ±0.4 mm; DV from the
cortical surface, −3.5 mm). The syringe remained at the target area for 5 min before a 5-min
baseline period of data collection began. At the end of the baseline period, the cholinergic
agonist carbachol (carbamylcholine chloride, 22 mM, Sigma, St. Louis, MO), dissolved in
phosphate buffered saline (PBS), or PBS alone, was infused (0.1 µL over 20 s). These
parameters for concentration and infusion rate were determined from pilot experiments and
previously published work (Xi et al., 2004; Karlsson et al., 2005; Karlsson & Blumberg,
2005). The order of carbachol and PBS infusion was counterbalanced such that 6 animals
received a carbachol infusion first and a PBS infusion 25 min later, and 6 animals received a
PBS infusion first and a carbachol infusion 25 min later. Side of infusion was also
counterbalanced. Finally, whereas both ipsilateral and contralateral EMG activity was recorded
in 4 subjects, either ipsilateral or contralateral activity (but not both) was recorded in the
remaining 8 subjects.
Experiment 2: Deactivation of the DLPT using scopolamine—Chemical lesions of
the PnO were performed using 6 P8 rats from 6 litters. Pups were prepared for testing as
described in Experiment 1. After 1 h of recovery, pups were placed into the stereotaxic
apparatus. A microsyringe (Model 7000.5OC; Hamilton Co., Reno, NV) was lowered into the
PnO (coordinates relative to lambda: AP, −1.0 mm; ML, ±1.0 mm; DV from the cortical
surface, −6.0 mm). The syringe remained at the target site for 5 min before highly concentrated
quisqualic acid (50 mM, 0.15 µl over 20 s) was infused bilaterally into the PnO. The pup was
then removed from the stereotaxic apparatus to recover for 3 h in a humidified incubator
maintained at 35°C. The pup was then returned to the stereotaxic instrument and allowed to
acclimate for 1 h before the test began.
A guide cannula (#C316-G-5UP, Plastics One, Roanoke, VA) was placed in the brain just
dorsal to LDT (coordinates relative to lambda; AP, −1.2 mm; ML, ±0.4 mm; DV from the
cortical surface, −2.5 mm). A microsyringe (Model 7000.5OC; Hamilton Co., Reno, NV) was
inserted into the guide cannula and lowered into the LDT (coordinates relative to lambda; AP,
− 1.2 mm; ML, ±0.4 mm; DV from the cortical surface, −3.5 mm) and either scopolamine (10
mM, 0.1 µl over 20 s) or PBS was administered. These parameters for concentration and
infusion rate were determined from pilot experiments and previously published work (Xi et
al., 2004; Karlsson et al., 2005; Karlsson & Blumberg, 2005). Scopolamine and PBS were
both administered to the same animal at 30-min intervals, with the order of drug administration
and the side of infusion counterbalanced between subjects. EMG activity was recorded for 5
min before and after infusion.
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Experiment 3: 2-DG mapping of the DLPT after lesions of the PnO—Pups were
prepared for testing as described in Experiment 1. As in Experiment 2, P8 rats (n = 2) received
bilateral infusions of quisqualic acid (50 mM, 0.15 µl over 20 s) into the PnO. Control
littermates (n = 2) received bilateral infusions of saline into the PnO. Littermates were then
placed separately in identical double-walled glass testing chambers that were humidified and
maintained at thermoneutrality (35°C). Air flow through each chamber was 300 ml/min. After
a 3-h recovery period, each pup was injected intraperitoneally with a glucose analog, 2-
deoxyglucose (2-DG) radiolabeled with 14C (18 µCi/100 g of body weight; American
Radiolabeled Chemicals, St. Louis, MO) in 0.05 ml of sterile saline. After the injection, nuchal
EMG activity was continuously monitored for 45 min (pups were unrestrained throughout the
recovery and testing period). Each pup was then decapitated and its brain quickly removed,
placed in hexane at −35°C, and then stored at −80°C until analyzed.
Experiment 4: Deactivation of the nucleus pontis oralis using lidocaine—Pups
were prepared for testing as described in Experiment 1. After acclimation to the stereotaxic
apparatus, head-fixed P8 rats (n = 6) received a unilateral infusion (0.2 µL over 15 s) of a 2%
solution of lidocaine (Sigma, St. Louis, MO) dissolved in saline, or saline alone, into the left
or right PnO. EMG activity in the ipsilateral and contralateral nuchal muscles was recorded
for 5 min before and after the infusion. Subjects served as their own controls. The order of
lidocaine or saline infusion was counterbalanced across subjects, with 30 min between each
infusion.
HISTOLOGY
At the conclusion of each test in Experiment 1, Experiment 2, and Experiment 4, pups were
overdosed with sodium pentobarbital and perfused transcardially with PBS followed by 10%
formalin. Brains were post-fixed in the skull for 1–2 d in a formalin-sucrose solution, removed
from the skull, and fixed again for at least 24 h in fresh formalin-sucrose solution. The brains
were then sliced in 50 µm sections using a sliding microtome (Model SM 2000 R, Leica,
Bensheim, Germany). Brain slices were stained using cresyl violet.
For the 2-DG experiment (Experiment 3), brains were sectioned using a cryostat at increments
of 40 µm. Each section was retained, with every fifth section set aside for cresyl violet staining.
The remaining sections were quick-dried on glass coverslips, glued on poster board, and
exposed to 14C phosphor imaging screens for 36 h along with 14C standards (Amersham
Biosciences, Arlington Heights, IL). The screens were read and digitized by a phosphor
imaging system (Cyclone Storage Phosphor System, PerkinElmer Life Sciences, Emeryville,
CA). For cresyl violet staining, sections were placed on a glass slide, allowed to dry for 24 h,
and soaked in 10% formalin for 30 min to fix the tissue before staining.
In Experiment 1, Experiment 2 and Experiment 4, infusion sites were located by noting syringe
tracks. In Experiment 2 and Experiment 3, the rostrocaudal extent of each lesion was
determined by examination of sequential brain slices for areas devoid of neurons. Lesions and
infusion sites were drawn using image software (Adobe Photoshop 5.5, Adobe, San Jose, CA,
USA).
DATA ANALYSIS
Experiment 1: Chemical stimulation of the DLPT with carbachol—Data were
analyzed off-line using Spike2 software. Ipsilateral and contralateral nuchal EMGs were
rectified and EMG amplitudes were averaged over 10-s intervals at the following time periods:
1 min before the infusion and 1, 3, and 6 min after the infusion. A site was considered tone-
producing if stimulation resulted in an increase in EMG amplitude of at least 2 standard
deviations above the average baseline value, as described elsewhere (Karlsson & Blumberg,
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2005). Percent change in EMG amplitude was calculated at each post-infusion time period in
relation to baseline. Group differences were tested using repeated-measures ANOVA and the
post hoc test was a paired t test. For this and subsequent experiments, ANOVAs were performed
separately for ipsilateral and contralateral muscles. For all tests, alpha was set at 0.05.
Experiment 2: Deactivation of the DLPT using scopolamine—Ipsilateral and
contralateral nuchal EMGs were rectified. EMG amplitudes were averaged over a 10-s interval
30 s before the infusion of scopolamine and 30, 60, 90, and 120 s after the infusion. Methods
for calculating percent change in EMG amplitude and statistical comparisons were identical
to those described for Experiment 1.
Experiment 3: 2-DG mapping of the DLPT after lesions of the PnO—
Autoradiographs of lesioned and sham animals were visually inspected for areas of increased
metabolism. The location of lesions within the PnO was assessed by inspection of the
autoradiographs as well as adjacent sections that were stained with cresyl violet.
Experiment 4: Deactivation of the PnO using lidocaine—Data were analyzed as
described above for Experiment 2.
For all experiments, means are presented with their standard errors (SE).
RESULTS
Infusion of carbachol within the DLPT produces high nuchal muscle tone
To determine whether chemical activation of the DLPT is capable of activating high muscle
tone, chemical infusions were performed. Because the DLPT, especially the LDT and PPT, of
adult rats is rich in muscarinic receptors (Baghdoyan, 1997), we infused carbachol into the
DLPT of unanesthetized, head-fixed pups.
As shown in Figure 1A, infusion of carbachol into the DLPT produced rapid and sustained
increases in EMG amplitude in both the ipsilateral and contralateral nuchal muscles. The EMG
responses of a single representative pup are depicted in Figure 1B. A repeated-measures
ANOVA revealed a significant effect of group on ipsilateral nuchal EMG amplitude (F(1,14)
= 11.0; p < 0.01) as well as a significant effect of time (F(3,42) = 4.7; p < 0.01) and a significant
group × time interaction (F(3,42) = 4.1; p < 0.05). Similarly, a repeated-measures ANOVA
revealed a significant effect of group on contralateral nuchal EMG amplitude (F(1,14) = 40.9;
p < 0.0001) as well as a significant effect of time (F(3,42) = 12.6; p < 0.0001) and a significant
group × time interaction (F(3,42) = 14.0; p < 0.0001).
Figure 1C indicates the sites of carbachol and PBS infusion. It can be seen that carbachol
infusions produced significant increases in muscle tone when placed in a variety of locations
throughout the DLPT, including subcoeruleus, LDT, and PB. In three instances, carbachol
infusions were not effective (“misses”); one of these infusions was placed in the central gray
adjacent to the fourth ventricle and the other two were placed within the PnO.
In several animals, the induction of high muscle tone by infusion of carbachol into the DLPT
was followed within 2–4 min by pronounced convulsions of the limbs, head, and tail, as well
as foaming at the mouth. These observations are consistent with previous studies reporting that
microinjections of carbachol into the pontine and mesencephalic reticular formation of adult
rats produces electroencephalographic seizures, including convulsions (Elazar & Feldman,
1987; Elazar & Berchanski, 2000).
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Infusion of scopolamine into the DLPT reverses the effects of PnO lesions on nuchal muscle
tone
Quisqualic acid lesions of the PnO produce, after several hours, chronically high nuchal muscle
tone in infant rats (Karlsson et al., 2005). Given the effects of carbachol infusion described
above, we hypothesized that PnO lesions activate muscle tone by directly or indirectly releasing
acetylcholine within the DLPT. Therefore, in this experiment, chemical lesions of the PnO
were used to produce high muscle tone, at which time scopolamine was infused into the DLPT.
We predicted that scopolamine infusion would reverse the effects of PnO lesions on nuchal
muscle tone.
As expected, bilateral quisqualic acid lesions within the PnO resulted in chronically high levels
of nuchal muscle tone. Then, as shown in Figure 2A, infusion of scopolamine into the DLPT
produced rapid decreases in EMG amplitude in both the ipsilateral and contralateral muscles.
The EMG responses of a single representative pup are depicted in Figure 2B. A repeated-
measures ANOVA revealed a significant effect of group on ipsilateral nuchal EMG amplitude
(F(1,10) = 6.8; p < 0.05) as well as a significant effect of time (F(4,40) = 2.6; p < 0.05) and a
significant group × time interaction (F(4,40) = 5.7; p < 0.005). Similarly, a repeated-measures
ANOVA revealed a significant effect of group on contralateral EMG amplitude (F(1,10) = 9.7;
p < 0.05) as well as a significant effect of time (F(4,40) = 4.4; p < 0.005) and a significant group
× time interaction (F(4,40) = 6.0; p < 0.001).
Figure 2C indicates the infusion sites and the extent of the lesions. Most of the scopolamine
infusion sites were located within and adjacent to LDT. The lesions were confirmed as being
within the PnO.
Metabolic mapping of the DLPT region after PnO lesions
Bilateral quisqualic acid lesions were produced in the PnO of two P8 rats while littermates
received sham lesions. Using nuchal EMG as our measure of sleep and wakefulness (Karlsson
et al., 2005; Seelke et al., 2005), data were recorded for 45 min before the pup was sacrificed
and its brain removed. As shown in Figure 3A, the two sham pups were awake 36% and 25%
of the time, whereas their lesioned littermates were awake 87% and 89% of the time,
respectively.
The locations of the PnO lesions are depicted in Figure 3B. The bottom row depicts the lesions
at the level of the superior colliculus based on sections stained with cresyl violet. The top row
presents autoradiographs for sections at the same level. First, we used the cresyl-violet sections
to determine the size and location of the lesions; it can be seen that these lesions were located
within the PnO. Next, examination of the autoradiographs at corresponding locations within
the PnO reveals regions of inactivation surrounded by halos of activation.
Figure 3C presents autoradiographs for the two pairs of lesion and sham subjects across four
sections within the mesopontine region. First, there is a clear difference in the overall level of
activity between the two groups; this finding is consistent with other 2-DG studies of metabolic
activity in sleeping and waking subjects (Nakamura et al., 1983; Nofzinger et al., 2002).
Second, and most important, the two subjects with PnO lesions exhibited pronounced and
specific increases in metabolic activity within the DLPT.
It is important to note that the 2-DG sections were cut at a different angle than those represented
in the other figures such that the dorsal regions were farther caudal relative to the ventral
regions. Thus, we carefully examined these sections to determine the level at which increased
activation occurred. For example, in Figure 3C, for the section that has been labeled, it was
determined that the region of heightened metabolic activity (indicated by the white arrow)
includes LDT medially and PB laterally.
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Infusion of lidocaine into the PnO produces high nuchal muscle tone
As shown in Figure 4A, unilateral infusion of lidocaine into the PnO of unanesthetized, head-
fixed pups produced rapid and pronounced increases in EMG amplitude in the contralateral
nuchal muscle; the EMG responses of a single representative pup are depicted in Figure 4B.
A repeated-measures ANOVA revealed a significant effect of group on contralateral EMG
amplitude (F(1,10) = 12.1; p < 0.01), but a non-significant effect of time (F(4,40) = 1.2) and a
non-significant group × time interaction (F(4,40) = 1.4). In contrast, a repeated-measures
ANOVA revealed neither a significant effect of group on ipsilateral EMG amplitude (F(1,10)
= 1.2) nor on time (F(4,40) = 1.4); the group × time interaction was also not significant
(F(4,40) = 1.3). Finally, Figure 4C indicates that the infusion sites were located within the PnO.
DISCUSSION
Fluctuations in skeletal muscle tone provide sufficient information to assess sleep and
wakefulness in infants at those ages when other components of sleep (e.g., neocortical EEG)
are not yet expressed (Seelke et al., 2005). Indeed, using nuchal atonia alone as an indicator
of sleep and wakefulness, state-dependent neurons have been identified in week-old rats
throughout the medulla, mesopontine region, hypothalamus, and basal forebrain that fall into
the same broad categories that have been identified in adults (Karlsson et al., 2005; Karlsson
& Blumberg, 2005; Mohns et al., 2006). Moreover, lesions of the DLPT and PnO produce
increased sleep and wakefulness, respectively (Karlsson et al., 2005).
The present study builds on these earlier reports and implicates the cholinergic system in the
modulation of muscle tone in early infancy in rats. First, in Experiment 1, we found that
chemical stimulation with the cholinergic agonist, carbachol, across a broad region within the
DLPT increased nuchal muscle tone. Next, in Experiment 2, we found that when the PnO was
lesioned to produce chronically high muscle tone, infusing scopolamine into the DLPT
decreased muscle tone. Together, these findings suggest that the PnO directly or indirectly
modulates muscle tone via the release of acetylcholine within the DLPT.
The spread of carbachol and scopolamine after the infusion to distant sites is a concern for the
interpretation of our results. We note, however, that the injection volumes used here were small
(0.1 µl) and many subjects exhibited nuchal EMG responses before the infusions were
completed (i.e., within 20 s). Moreover, as shown in Figure 1, three infusions dorsal and ventral
to the DLPT, including one adjacent to the fourth ventricle, failed to produce significant
increases in muscle tone during the 5-min test. Thus, the effects of the infusions reported here
do not appear to be due to diffusion of chemicals to distant sites. Nonetheless, the use of more
precise methods will be needed to further delineate the neural mechanisms modulating
behavioral state in early infancy.
Consistent with the present findings, it was recently reported (Boissard et al., 2002) that
carbachol infusion into the pontine sublaterodorsal nucleus (SLD) of adult rats produces
wakefulness. In contrast, carbachol infusion into a homologous location within the pontine
reticular formation of cats induces active sleep (Chase & Morales, 1990; Xi et al., 2004).
Although rats and cats may differ with regard to the sleep-promoting effects of carbachol,
including the ability of carbachol to trigger REM sleep>, there may be similar non-cholinergic
mechanisms within the pontine reticular formation with regard to the generation of sleep and
wakefulness in these two species (Xi et al., 1999; Boissard et al., 2002; Boissard et al., 2003;
Luppi et al., 2004). In rats, GABA antagonists infused into the SLD produce a state akin to
REM sleep (Boissard et al., 2002). Building on this finding, it was recently proposed that the
SLD and related nuclei act in opposition to the lateral pontine tegmentum to produce transitions
between REM and NREM sleep (Lu et al., 2006). The present results suggest that these lateral
pontine nuclei also contribute to the production of wakefulness.
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Based in part on the now-disputed notion that the cholinergic system is essential for the
production of REM sleep in adults, and that this system may not yet be functionally mature in
early infancy (i.e., before P11 in rats), it was hypothesized (Frank & Heller, 2003) that infant
and adult sleep are qualitatively distinct. This hypothesis, as well as the related contention that
infant sleep, however defined, does not rely on executive brain mechanisms, is not supported
by recent evidence (Karlsson et al., 2004; Karlsson et al., 2005; Karlsson & Blumberg,
2005; Mohns et al., 2006). Moreover, the present results, especially those from Experiment 2
in which scopolamine reversed the high muscle tone evoked by PnO lesions, suggest that the
cholinergic system is involved in the modulation of wakefulness before P11.
Baghdoyan (1997) established the prevalence of muscarinic receptor subtypes (i.e., M1, M2,
M3) within the adult rat pons, including the DLPT. In addition, it has been shown that these
muscarinic receptors exhibit high affinity for acetylcholine in neonates (Heacock et al.,
1987; Semba, 1992). That there is a dense projection of neurons from the PnO to the DLPT
(Semba & Fibiger, 1992) provides an anatomical foundation for the current finding concerning
the excitatory effect of PnO lesions on muscle tone and the reversal of this effect when
scopolamine is infused into the DLPT. Finally, cholinergic projections from the DLPT to
cholinoceptive cells within the PnO (Shiromani et al., 1988; Jones, 1990; Lai et al., 1993)
suggest that there may be reciprocal interactions between these two regions, though such
reciprocal interactions were not examined here.
To assess the region of activation during the sustained wakefulness that follows PnO lesions,
we used 2-DG autoradiography in Experiment 3. Chemical or sham lesions of the PnO were
used to produce littermates that differed substantially in the amount of wakefulness exhibited
during the period of 2-DG uptake. In relation to shams, pups with PnO lesions exhibited higher
overall levels of metabolic activity in every brain section examined; this is consistent with
previous metabolic mapping studies in sleeping and waking monkeys and humans (Nakamura
et al., 1983; Nofzinger et al., 2002). More importantly, a wide swath of tissue within the DLPT
exhibited a marked increase in metabolic activity in the lesioned subjects. This finding adds
support to the notion that lesions of the PnO disinhibit activity within the DLPT and thereby
increase muscle tone.
In this study, quisqualic acid lesions of the PnO were produced in anesthetized infants and pups
were tested several hours later. As shown previously (Karlsson et al., 2005), this protocol
results in the destruction of neurons at the infusion site. In the 2-DG experiment here,
examination of the brain sections stained with cresyl violet again indicated loss of neurons.
Examination of the autoradiographs, however, revealed areas of inactivation surrounded by
halos of activation (see Figure 3B). These halos could reflect the recruitment of metabolically
active glia in response to lesion-induced cell death, the disinhibition of neurons adjacent to the
lesion, or even residual activation of neurons by quisqualic acid. Because we noticed that the
effect of highly concentrated quisqualic acid on muscle tone develops gradually over time
(presumably as neurons are killed by overexcitation), it seems unlikely that the increased EMG
activity reported here, and elsewhere (Karlsson et al., 2005), can be attributed to excitation or
disinhibition of neurons in surrounding tissue. This conclusion is consistent with reports in
adult rats that chemical stimulation within the PnO produces atonia (Hajnik et al., 2000).
Moreover, as shown here in Experiment 4, the converse is also true: inactivation of PnO neurons
using the sodium channel blocker, lidocaine, produces a rapid increase in muscle tone.
Carbachol can have excitatory or inhibitory effects on state-dependent neurons within the LDT
and other mesopontine nuclei (Semba, 1999). With regard to this issue, we have found that
electrolytic lesions of the DLPT suppress wakefulness (Karlsson et al., 2005). Moreover, as
shown here, the increased wakefulness produced by PnO lesions also increases metabolic
activity within the DLPT, that scopolamine infusion into the DLPT reverses the effect of PnO
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lesions on wakefulness, and that carbachol infusion into the DLPT increases wakefulness. All
together, these results provide converging evidence that, at least in infant rats, cholinoceptive
neurons within the DLPT induce wakefulness when they are excited.
In the experiments in which carbachol and scopolamine were infused into the DLPT, equivalent
ipsilateral and contralateral effects were found (see Figure 1 and Figure 2). In contrast, lidocaine
infusion into the PnO evoked a significant activational effect only on the contralateral nuchal
muscle (see Figure 4). These results suggest that the DLPT exerts bilateral effects on muscle
tone, whereas the PnO’s effects may involve only contralateral control. Whether this
conclusion is consistent with a report in adult rats showing age-related differences in the
bilateral inhibition of muscle tone with electrical stimulation of the PnO (Hajnik et al., 2000),
remains unclear at this time.
In summary, the production of high muscle tone during DLPT activation appears mediated by
the release of acetylcholine, thereby establishing a functional role for this neurotransmitter in
early infancy. Moreover, the present study suggests that the DLPT and PnO comprise part of
the nascent neural circuit that modulates infant muscle tone and sleep-wake cyclicity. Thus,
the present results advance our understanding of the basic neural circuitry governing one of
the first behavioral processes to emerge in early development.
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Carbachol infusion into the dorsolateral pontine tegmentum produces increased nuchal muscle
tone in P8–10 rats. (A) Percentage change in nuchal EMG amplitude from baseline after
ipsilateral (n=10) or contralateral (n=6) infusion of the cholinergic agonist carbachol or vehicle
(PBS). Amplitudes were averaged over the 10-s period immediately before infusion and at 1,
3, and 6 min after the infusion. * Significant difference between groups. N=12 subjects per
group. Mean ± SE. (B) Representative ipsilateral and contralateral nuchal EMG responses to
infusion of carbachol (22 mM). The arrow indicates the onset of the infusion (0.1 µL over 20
s). (C) Coronal sections of the brainstem to indicate infusion sites. Carbachol infusion sites are
marked by Xs; vehicle (PBS) infusion sites are marked by circles; misses (i.e., carbachol
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infusion sites where muscle tone was not increased) are marked by squares. Abbreviations: IC,
inferior colliculus; LC, locus coeruleus; DR, dorsal raphé; LDT, laterodorsal tegmental
nucleus; PB, parabrachial nucleus; DT, dorsal tegmental nucleus; PnO, nucleus pontis oralis;
PAG, periaqueductal gray; PPT, pedunculopontine tegmental nucleus; SC, superior colliculus.
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Infusion of scopolamine into the dorsolateral pontine tegmentum (DLPT) reverses the effects
of lesions of the nucleus pontis oralis (PnO) on nuchal muscle tone in P8–10 rats. (A)
Percentage change in ipsilateral and contralateral nuchal EMG amplitude from baseline after
infusion of the cholinergic antagonist scopolamine or vehicle (PBS). Both scopolamine and
vehicle were infused at the same site with order counterbalanced. * Significant difference
between groups. N=6 subjects per group. Mean ± SE. (B) For a representative subject,
ipsilateral and contralateral nuchal EMG responses to infusion of scopolamine (10 mM) into
the DLPT. The arrow indicates the onset of the infusion (0.1 µL over 20 s). (C) Coronal sections
of the brainstem to indicate lesion and infusion sites. The smallest and largest lesions of the
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PnO within each brain section are denoted by the gray and black areas, respectively. Infusion
sites are marked by Xs. Abbreviations as in Figure 1.
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Metabolic activity within the dorsolateral pontine tegmentum (DLPT) increases after lesions
of the nucleus pontis oralis (PnO) in P8 rats. Two rats from two litters (denoted Litter 1 and
Litter 2) received chemical lesions of the PnO; two littermates received sham lesions. Each
pup was injected with 2-DG and then allowed to cycle normally between sleep and wakefulness
for 45 min before its brain was removed. (A) Percentage of time awake for the lesion (filled
bars) and sham (unfilled bars) pups during the 45-min period after injection of 2-DG. (B) Top
row: 2-DG autoradiographs depicting lesions within the PnO for each of the two pups. Lesion
sites are indicated by areas of inactivation surrounded by halos of increased activation. For one
site (Litter 1), the syringe track can also be seen. Bottom row: Lesion sites as determined by
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inspection of sections stained with cresyl violet. In both cases, filled regions indicate areas
devoid of neurons. (C) 2-DG autoradiographs for each of the four subjects. The white arrow
indicates increased metabolic activation within a region of the DLPT that includes the
parabrachial nucleus and laterodorsal tegmental nucleus. Overall levels of metabolic activity
are higher in the lesion pups in relation to the shams. Abbreviations: IC, inferior colliculus;
Cb, cerebellum; mcb, middle cerebellar peduncle.
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Infusion of lidocaine into the nucleus pontis oralis (PnO) produces increased nuchal muscle
tone in P8–10 rats. (A) Percentage change in ipsilateral and contralateral EMG amplitude from
baseline after infusion of lidocaine (2%) or vehicle (PBS). (B) Representative nuchal EMG
responses to infusion of lidocaine. The arrow indicates the onset of the infusion (0.2 µL over
15 s). (C) Coronal sections of the brainstem to indicate infusion sites. Lidocaine infusion sites
are marked by Xs; vehicle infusion sites are marked by filled circles. Abbreviations as in Figure
1.
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